Browse by Medical Category
Department of Radiation Oncology
Our team includes some of the most experienced radiation oncologists treating genitourinary (GU) cancers in the United States. Each year we manage radiation therapy for many hundreds of patients with cancers and tumors of the prostate, bladder, kidneys, testes, penis, ureters, and urethra. Our specialists are involved in all aspects of GU cancer care including new targeted biologic therapies combined with radiation as well as quality of life research.
Our unique expertise lies in the areas of active surveillance for prostate cancer, proton beam therapy, and the management of bladder cancer using chemotherapy and radiation. In addition our investigators lead major national and international trials to determine the most effective use of these and other novel approaches.
The Genitourinary Program uses the latest state-of-the-art and innovative technologies including:
The genitourinary division is well integrated with their counterparts in urology and medical oncology, having shared protocols for three decades and multidisciplinary clinics for nearly two decades. The Claire and John Bertucci Center for Genitourinary (GU) Cancers at Massachusetts General Hospital Cancer Center is one of the largest and most experienced centers in New England for the treatment of genitourinary cancers. Many of the advanced diagnostic and therapeutic approaches available here are offered at only a few other centers nationwide.
Every step of your radiation therapy is managed by an experienced radiation oncologist who has devoted his or her clinical practice, research and postdoctoral training to treating patients with GU cancers.
Our physician staff includes:
We encourage you to ask us about any step in the treatment process, from understanding the safety of your therapy to managing side effects. The answers to many frequently asked questions also appear in Your Guide to Radiation Therapy (PDF).
Massachusetts General Hospital invites patients and the community to participate in innovative clinical trials and research studies.
Search open clinical trials.
Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer (PARTIQoL) clinical trial.
Clark Center for Radiation Oncology
Vida E & Arthur L. Goldstein Lunder Building
Francis H. Burr Proton Therapy Center30 Fruit StreetBoston, MA 02114Phone: 617-726-0923 (Proton Inquiry Line: 617-724-1680)Fax: 617-726-6498Email: InformationRadOnc@partners.org
Back to Top